Home
GILD
GILD News

Latest Gilead Sciences Inc. (GILD) News on February 22, 2025

Argus Research

a day ago

Analyst Report: Gilead Sciences, Inc.

Gilead’s lenacapavir under priority review could revolutionise HIV PrEP

Clinical Trials Arena

a day ago

Gilead’s lenacapavir under priority review could revolutionise HIV PrEP

Argus Research

a day ago

Market Update: BKNG, THRM, DHI, GILD, WMT, XYZ

MT Newswires

a day ago

Bernstein Adjusts Gilead Sciences Price Target to $120 From $105

Some Investors May Be Willing To Look Past Gilead Sciences' (NASDAQ:GILD) Soft Earnings

Simply Wall St.

a day ago

Some Investors May Be Willing To Look Past Gilead Sciences' (NASDAQ:GILD) Soft Earnings

Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup

Quartz

a day ago

Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup

MT Newswires

2 days ago

Gilead Sciences Gets Conditional Marketing Authorization for Liver Disease Treatment in European Economic Area

Gilead’s Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis

Business Wire

2 days ago

Gilead’s Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis

GILD or VRTX: Which Is the Better Value Stock Right Now?

Zacks

2 days ago

GILD or VRTX: Which Is the Better Value Stock Right Now?

Gilead Sciences, Inc. (GILD): Among Stocks That Analysts Think Will Go Up

Insider Monkey

2 days ago

Gilead Sciences, Inc. (GILD): Among Stocks That Analysts Think Will Go Up

Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year?

Zacks

2 days ago

Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year?

High Growth Tech Stocks in the United States to Watch

Simply Wall St.

2 days ago

High Growth Tech Stocks in the United States to Watch

Gilead Sciences to Present at Upcoming Investor Conferences

Business Wire

3 days ago

Gilead Sciences to Present at Upcoming Investor Conferences

Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News

Zacks

3 days ago

Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News

Sanofi reaches consumer health deal; Supernus antidepressant fails study

BioPharma Dive

3 days ago

Sanofi reaches consumer health deal; Supernus antidepressant fails study

Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use

Pharmaceutical Technology

4 days ago

Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use

Gilead Sciences Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

4 days ago

Gilead Sciences Full Year 2024 Earnings: Beats Expectations

A new HIV prevention drug could get FDA approval this year

Quartz

4 days ago

A new HIV prevention drug could get FDA approval this year

Investing.com

4 days ago

Deutsche Bank upgrades Gilead on its HIV treatment franchise

MT Newswires

4 days ago

Cantor Fitzgerald Adjusts Gilead Sciences Price Target to $100 From $80, Maintains Neutral Rating

MT Newswires

4 days ago

DBS Bank Adjusts Gilead Sciences Price Target to $125 From $100

MT Newswires

4 days ago

Gilead Sciences Says New Drug Application for Lenacapavir to Prevent HIV Accepted by FDA

U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review

Business Wire

4 days ago

U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review

MT Newswires

4 days ago

Deutsche Bank Upgrades Gilead Sciences to Buy From Hold, Adjusts Price Target to $120 From $80

MT Newswires

4 days ago

Redburn Atlantic Adjusts Price Target on Gilead Sciences to $126 From $125, Maintains Buy Rating

Gilead Stock Rises 8% Post Q4 Earnings: Should You Buy or Sell?

Zacks

5 days ago

Gilead Stock Rises 8% Post Q4 Earnings: Should You Buy or Sell?

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Zacks

5 days ago

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Gilead Sciences, Inc. (GILD) Hit a 52 Week High, Can the Run Continue?

Zacks

5 days ago

Gilead Sciences, Inc. (GILD) Hit a 52 Week High, Can the Run Continue?

Gilead Sciences, Inc. (GILD): A Bull Case Theory

Insider Monkey

5 days ago

Gilead Sciences, Inc. (GILD): A Bull Case Theory

Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.79

Simply Wall St.

7 days ago

Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.79

MT Newswires

8 days ago

Gilead Sciences Insider Sold Shares Worth $14,073,241, According to a Recent SEC Filing

Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance

Zacks

9 days ago

Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance

MT Newswires

9 days ago

Daiwa Securities Adjusts Price Target on Gilead Sciences to $104 From $90, Keeps Neutral Rating

MT Newswires

9 days ago

IDEAYA Biosciences Launching Gilead Trial Collaboration to Evaluate Trodelvy, IDE397 Combination in Lung Cancer

Gilead Sciences (GILD) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

9 days ago

Gilead Sciences (GILD) is a Top-Ranked Momentum Stock: Should You Buy?

3 US Stocks Estimated Up To 48.1% Undervalued Based On Intrinsic Value Estimates

Simply Wall St.

9 days ago

3 US Stocks Estimated Up To 48.1% Undervalued Based On Intrinsic Value Estimates

S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth

Investopedia

10 days ago

S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth

Gilead Hits Buy Zone After Obliterating Fourth-Quarter Expectations

Investor's Business Daily

10 days ago

Gilead Hits Buy Zone After Obliterating Fourth-Quarter Expectations

Why Gilead Sciences (GILD) Stock Is Trading Up Today

StockStory

10 days ago

Why Gilead Sciences (GILD) Stock Is Trading Up Today

Why Gilead Sciences Stock Is Jumping Today

Motley Fool

10 days ago

Why Gilead Sciences Stock Is Jumping Today

Morningstar Research

10 days ago

Analyst Report: Gilead Sciences, Inc.

Gilead Sciences (GILD) is a Top-Ranked Value Stock: Should You Buy?

Zacks

10 days ago

Gilead Sciences (GILD) is a Top-Ranked Value Stock: Should You Buy?

MT Newswires

10 days ago

JPMorgan Adjusts Price Target on Gilead Sciences to $120 From $115

MT Newswires

10 days ago

Baird Adjusts Price Target on Gilead Sciences to $100 From $95

MT Newswires

10 days ago

Wells Fargo Adjusts Price Target on Gilead Sciences to $120 From $105

MT Newswires

10 days ago

TD Cowen Adjusts Price Target on Gilead Sciences to $100 From $95

MT Newswires

10 days ago

Goldman Sachs Adjusts Price Target on Gilead Sciences to $96 From $85

MT Newswires

10 days ago

Piper Sandler Adjusts Price Target on Gilead Sciences to $110 From $105

MT Newswires

10 days ago

BMO Capital Adjusts Price Target on Gilead Sciences to $115 From $110

GILD Stock Up on Q4 Earnings and Sales Beat & Upbeat '25 Guidance

Zacks

10 days ago

GILD Stock Up on Q4 Earnings and Sales Beat & Upbeat '25 Guidance

The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.

The Wall Street Journal

11 days ago

The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.

Coca-Cola results, Powell testifies, SMCI update: What to Watch

Yahoo Finance Video

12 days ago

Coca-Cola results, Powell testifies, SMCI update: What to Watch

Gilead Sciences (GILD) Q4 Earnings: What To Expect

StockStory

12 days ago

Gilead Sciences (GILD) Q4 Earnings: What To Expect

Argus Research

12 days ago

Weekly Stock List

The Zacks Analyst Blog Uber, Comcast, Gilead Sciences and Onfolio Holdings

Zacks

12 days ago

The Zacks Analyst Blog Uber, Comcast, Gilead Sciences and Onfolio Holdings

3 Fabulous Dividend Stocks to Buy in February

Motley Fool

13 days ago

3 Fabulous Dividend Stocks to Buy in February

These 2 Dividend Stocks Are Absolute Bargains Right Now

Motley Fool

14 days ago

These 2 Dividend Stocks Are Absolute Bargains Right Now

Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards?

Zacks

15 days ago

Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards?

3 Top AI-Powered Biotech Stocks to Buy in February

Motley Fool

16 days ago

3 Top AI-Powered Biotech Stocks to Buy in February

Ahead of Gilead (GILD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks

16 days ago

Ahead of Gilead (GILD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

17 days ago

Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing

Is Gilead Sciences (GILD) the Best Wide Moat Stock to Invest In?

Insider Monkey

17 days ago

Is Gilead Sciences (GILD) the Best Wide Moat Stock to Invest In?

Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks

18 days ago

Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

MT Newswires

18 days ago

Deutsche Bank Adjusts Price Target on Gilead Sciences to $80 From $73

MT Newswires

18 days ago

Gilead Sciences Insider Sold Shares Worth $13,822,740, According to a Recent SEC Filing

Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts

Zacks

19 days ago

Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

19 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report?

Zacks

22 days ago

Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report?

Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy

Pharmaceutical Technology

22 days ago

Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

22 days ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Gilead Sciences, Inc. (GILD): AI Partnerships Enhancing Biopharmaceutical Advancements

Insider Monkey

22 days ago

Gilead Sciences, Inc. (GILD): AI Partnerships Enhancing Biopharmaceutical Advancements

MT Newswires

23 days ago

Cognizant to Provide Gilead With AI-Driven Tools Under Expanded Partnership

Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications

PR Newswire

23 days ago

Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications

Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock

Zacks

24 days ago

Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock

MT Newswires

24 days ago

BMO Capital Adjusts Price Target on Gilead Sciences to $110 From $102, Maintains Outperform Rating

MT Newswires

24 days ago

JPMorgan Adjusts Price Target on Gilead Sciences to $115 From $105, Maintains Overweight Rating

Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts

Zacks

25 days ago

Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts

Gilead Sciences to Release Fourth Quarter & Full Year 2024 Financial Results on Tuesday, February 11, 2025

Business Wire

25 days ago

Gilead Sciences to Release Fourth Quarter & Full Year 2024 Financial Results on Tuesday, February 11, 2025

Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views?

Zacks

25 days ago

Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views?

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on Gilead Sciences to $85 From $84, Keeps Neutral Rating

Why Gilead Sciences (GILD) Is One of the Best Humane Stocks to Invest in Now?

Insider Monkey

a month ago

Why Gilead Sciences (GILD) Is One of the Best Humane Stocks to Invest in Now?

GILD vs. ALNY: Which Stock Is the Better Value Option?

Zacks

a month ago

GILD vs. ALNY: Which Stock Is the Better Value Option?

Exploring High Growth Tech Stocks in January 2025

Simply Wall St.

a month ago

Exploring High Growth Tech Stocks in January 2025

MT Newswires

a month ago

RBC Adjusts Price Target on Gilead Sciences to $84 From $83, Maintains Sector Perform Rating

Why Gilead Sciences (GILD) Outpaced the Stock Market Today

Zacks

a month ago

Why Gilead Sciences (GILD) Outpaced the Stock Market Today

Is Gilead Sciences (GILD) Among Billionaire Steve Cohen’s Top Stock Picks?

Insider Monkey

a month ago

Is Gilead Sciences (GILD) Among Billionaire Steve Cohen’s Top Stock Picks?

Can Gilead Sciences Sustain Its Growth Momentum in 2025?

Zacks

a month ago

Can Gilead Sciences Sustain Its Growth Momentum in 2025?

House of the Week: A Riverfront Retreat in Southeastern Connecticut

The Wall Street Journal

a month ago

House of the Week: A Riverfront Retreat in Southeastern Connecticut

The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences

Zacks

a month ago

The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences

Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others

Zacks

a month ago

Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others

Is Gilead Sciences (GILD) Among the Best NASDAQ Dividend Stocks to Buy?

Insider Monkey

a month ago

Is Gilead Sciences (GILD) Among the Best NASDAQ Dividend Stocks to Buy?

Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?

Zacks

a month ago

Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?

Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Zacks

a month ago

Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Gilead Sciences, US government settle patent case over HIV prevention drugs

Reuters

a month ago

Gilead Sciences, US government settle patent case over HIV prevention drugs

Gilead, LEO Pharma Partner in $1.7 Billion Deal for Inflammatory Disease Therapies

GuruFocus.com

a month ago

Gilead, LEO Pharma Partner in $1.7 Billion Deal for Inflammatory Disease Therapies

Gilead and LEO Pharma link on programmes for inflammatory conditions

Pharmaceutical Technology

a month ago

Gilead and LEO Pharma link on programmes for inflammatory conditions

MT Newswires

a month ago

Gilead Sciences Partners With LEO Pharma on Inflammatory Disease Therapies

Gilead, LEO Pharma partner to develop programs for inflammatory diseases

Reuters

a month ago

Gilead, LEO Pharma partner to develop programs for inflammatory diseases

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases

Business Wire

a month ago

Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases

MT Newswires

a month ago

Redburn Atlantic Adjusts Price Target on Gilead Sciences to $125 From $123, Keeps Buy Rating

Share on Social Networks: